Literature DB >> 16477238

Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk.

Marek J Nowicki1, Claudia Chinchilla, Livier Corado, Lea Matsuoka, Rick Selby, Frank Steurer, Thomas Mone, Robert Mendez, Sali Aswad.   

Abstract

Trypanosoma cruzi, a parasite that causes Chagas' disease, is endemic in parts of Mexico, South America, and Central America. Transmission of T. cruzi infection by solid organ transplantation has been reported in Latin America and recently in the United States. To determine the prevalence of T. cruzi antibodies in Southern California organ donors, 404 samples from deceased organ donors between May 2002 to April 2004 were screened using a qualitative enzyme-linked immunosorbent assay (EIA) and confirmed with an immunofluorescence assay (IFA) available through the Centers for Disease Control (CDC). Six donors were initially reactive by EIA. Three donors were repeatedly reactive after repeat testing and were sent to the CDC for confirmation. One donor (0.25%) had an IFA-confirmed reactivity to anti-T. cruzi antibodies. In areas where there is a high number of immigrants from T. cruzi endemic countries, screening for anti-T. cruzi donor antibodies may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16477238     DOI: 10.1097/01.tp.0000195778.08411.b8

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Neurochemical coding of the enteric nervous system in chagasic patients with megacolon.

Authors:  A B M da Silveira; D D'Avila Reis; E C de Oliveira; S G Neto; A O Luquetti; D Poole; R Correa-Oliveira; J B Furness
Journal:  Dig Dis Sci       Date:  2007-03-24       Impact factor: 3.199

Review 2.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

3.  Design of e-pharmacophore models using compound fragments for the trans-sialidase of Trypanosoma cruzi: screening for novel inhibitor scaffolds.

Authors:  Bill R Miller; Adrian E Roitberg
Journal:  J Mol Graph Model       Date:  2013-08-16       Impact factor: 2.518

Review 4.  Diagnosis and Management of Chagas Cardiomyopathy in the United States.

Authors:  Lillian Benck; Evan Kransdorf; Jignesh Patel
Journal:  Curr Cardiol Rep       Date:  2018-10-11       Impact factor: 2.931

5.  Bioluminescent imaging of Trypanosoma cruzi infection.

Authors:  Kenneth V Hyland; Sofya H Asfaw; Cheryl L Olson; Melvin D Daniels; David M Engman
Journal:  Int J Parasitol       Date:  2008-04-25       Impact factor: 3.981

6.  Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

Authors:  Zuleima C Caballero; Octavio E Sousa; Waldelania P Marques; Amadeo Saez-Alquezar; Eufrosina S Umezawa
Journal:  Clin Vaccine Immunol       Date:  2007-05-23

7.  Mother-to-child transmission of Chagas' disease in North America: why don't we do more?

Authors:  Pierre Buekens; Olivia Almendares; Yves Carlier; Eric Dumonteil; Mark Eberhard; Rubi Gamboa-Leon; Mark James; Nicolas Padilla; Dawn Wesson; Xu Xiong
Journal:  Matern Child Health J       Date:  2007-06-30

8.  Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.

Authors:  Carme Roca; María Jesús Pinazo; Paolo López-Chejade; Joan Bayó; Elizabeth Posada; Jordi López-Solana; Montserrat Gállego; Montserrat Portús; Joaquim Gascón
Journal:  PLoS Negl Trop Dis       Date:  2011-04-26

9.  Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.

Authors:  Denise da Gama Jaén Batista; Marcos Meuser Batista; Gabriel Melo de Oliveira; Constança Carvalho Britto; Ana Carolina Mondaine Rodrigues; Chad E Stephens; David W Boykin; Maria de Nazaré Correia Soeiro
Journal:  PLoS One       Date:  2011-07-26       Impact factor: 3.240

10.  Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi.

Authors:  Stephen Brand; Eun Jung Ko; Elisabet Viayna; Stephen Thompson; Daniel Spinks; Michael Thomas; Lars Sandberg; Amanda F Francisco; Shiromani Jayawardhana; Victoria C Smith; Chimed Jansen; Manu De Rycker; John Thomas; Lorna MacLean; Maria Osuna-Cabello; Jennifer Riley; Paul Scullion; Laste Stojanovski; Frederick R C Simeons; Ola Epemolu; Yoko Shishikura; Sabrinia D Crouch; Tania S Bakshi; Christopher J Nixon; Iain H Reid; Alan P Hill; Tim Z Underwood; Sean J Hindley; Sharon A Robinson; John M Kelly; Jose M Fiandor; Paul G Wyatt; Maria Marco; Timothy J Miles; Kevin D Read; Ian H Gilbert
Journal:  J Med Chem       Date:  2017-08-27       Impact factor: 7.446

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.